VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
GDRX
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
GDRXGoodRx Holdings, Inc.
$3.32$1.2B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
  1. Home
  2. Financial Ratios

  1. Home
  2. Stocks
  3. GDRX
  4. Financial Ratios

GoodRx Holdings, Inc. (GDRX) Financial Ratios

Latest Ratios: P/E Ratio 38.9x · EV/EBITDA 8.3x · ROE 4.5%. (2018–2025 historical series)

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly

GDRX Valuation Multiples

Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Market Cap$1.2B$967M$1.8B$2.7B$1.9B$13.4B$11.1B——
Enterprise Value$1.4B$1.2B$1.9B$2.8B$1.9B$13.2B$10.8B——
P/E Ratio →38.9231.77111.24——————
P/S Ratio1.441.212.303.662.5117.9720.12——
P/B Ratio1.921.572.523.612.3616.1115.58——
P/FCF7.005.8916.0633.3121.0192.84116.01——
P/OCF6.855.769.9219.8813.1174.9484.37——

P/E links to full P/E history page with 30-year chart

GDRX EV Ratios

Enterprise-value multiples — capital-structure-neutral measures of total business value

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
EV / Revenue—1.572.423.722.4617.6519.64——
EV / EBITDA8.297.2314.1734.5633.69274.47———
EV / EBIT16.3612.5922.742411.66171.07977.30———
EV / FCF—7.5916.9033.7820.5791.18113.25——

GDRX Profitability

Margins and return-on-capital ratios measuring operating efficiency

Margins

Full margin charts and quarterly trend are on the Earnings History page

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Gross Margin92.8%92.8%93.9%91.1%91.5%93.7%94.6%96.4%97.6%
Operating Margin11.0%11.0%8.3%-3.6%0.2%1.8%-50.1%36.0%31.0%
Net Profit Margin3.8%3.8%2.1%-1.2%-4.3%-3.4%-53.3%17.0%17.6%

Return on Capital

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
ROE4.5%4.5%2.2%-1.1%-4.0%-3.3%-41.3%——
ROA2.2%2.2%1.1%-0.6%-2.0%-1.6%-31.6%18.8%13.9%
ROIC7.6%7.6%6.1%-2.6%0.2%1.9%-920.1%——
ROCE7.2%7.2%4.8%-1.8%0.1%0.9%-31.3%42.9%25.9%

GDRX Leverage & Debt

Solvency and debt-coverage ratios — lower is generally safer

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Debt / Equity0.880.880.750.930.880.840.99——
Debt / EBITDA3.143.144.018.8212.8214.65—4.648.30
Net Debt / Equity—0.460.130.05-0.05-0.29-0.37——
Net Debt / EBITDA1.631.630.700.48-0.72-4.98—4.477.90
Debt / FCF—1.710.840.47-0.44-1.65-2.768.8316.45
Interest Coverage2.332.331.590.020.320.57-9.872.673.36

GDRX Liquidity & Efficiency

Short-term solvency ratios and asset-utilisation metrics

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Current Ratio2.612.615.327.1212.0513.4218.242.594.40
Quick Ratio2.612.615.327.1212.0513.4218.242.594.40
Cash Ratio1.061.063.625.499.9211.6016.270.782.08
Asset Turnover—0.570.570.470.480.460.371.000.79
Inventory Turnover—————————
Days Sales Outstanding—116.7474.0977.8657.9361.9064.4952.2051.23

GDRX Shareholder Yields

Earnings, FCF, buyback, and dividend yields — total returns to shareholders

Dividends

Full dividend history and growth charts are on the Dividend History page

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Dividend Yield—————————
Payout Ratio————————3074.4%

Total Shareholder Return Metrics

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Earnings Yield2.6%3.1%0.9%——————
FCF Yield14.3%17.0%6.2%3.0%4.8%1.1%0.9%——
Buyback Yield18.0%21.4%8.7%3.8%5.3%0.0%0.0%——
Total Shareholder Yield18.0%21.4%8.7%3.8%5.3%0.0%0.0%——
Shares Outstanding—$357M$392M$410M$413M$410M$275M$363M$363M

Key Metrics

Growth RegimeDecelerating
ProfitabilityStable
Balance SheetAdequate
Cash FlowStable
Top Statement Risk

PBM disintermediation and flat growth

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q2)

Gross Margin Volatility Masks Core Stability

Gross margin swung from 93.4% in 2025Q1 to 78.4% in 2026Q1 before recovering to 89.5% in 2026Q2, per quarterly filings, indicating instability in cost of revenue despite a structurally high-margin model.

The 15-point gross margin swing in 2026Q1 likely reflects one-time adjustments or contract renegotiations, but the recovery to 89.5% suggests the underlying take-rate remains intact. Operating margin has hovered between 7.5% and 13.6% over the past year, with net margin consistently below 6.3%, implying that heavy SG&A spending—particularly sales and marketing—absorbs most of the gross profit. This gap between gross and net margins underscores that GDRX's earning power is constrained by customer acquisition costs, not by the cost of delivering its digital service.

ROIC Stagnates Near 2% Despite Asset-Light Model

ROIC has remained below 2.3% for the past ten quarters, per financial statements, despite an asset-light model with minimal capex, indicating that returns on invested capital are not compounding and may reflect a mature, low-growth phase.

ROIC peaked at 2.3% in 2025Q2 and has since drifted to 1.9% in 2026Q2, while ROE has stayed under 2% throughout. The low returns are driven by a combination of thin net margins and a large invested capital base, which includes significant goodwill and intangibles from prior acquisitions. Even with high gross margins, the company's inability to convert revenue into meaningful net income limits return generation, suggesting that capital allocation—such as the $300M+ in buybacks—has not yet improved per-share returns.

DSO Spike Signals Collection Strain

Days sales outstanding jumped from 74 days in 2024Q4 to 341 days in 2026Q2, per quarterly data, a dramatic deterioration that may indicate slower collections from PBM partners or a change in revenue mix, warranting close monitoring.

The DSO increase is anomalous and could be driven by timing of manufacturer solutions revenue or a shift in payment terms with major PBMs. Meanwhile, DPO has been volatile, ranging from 36 to 255 days, and the cash conversion cycle is not calculable due to missing DIO data, but the working capital swings have been significant, as seen in cash flow statements. This inefficiency in receivables may pressure liquidity, especially as the current ratio has fallen from 5.32 to 1.38 over the same period, suggesting that the company is holding less buffer against collection delays.

Debt Coverage Thins as Interest Costs Rise

Interest coverage has declined from 2.82 in 2025Q2 to 2.58 in 2026Q2, per reported figures, while D/EBITDA has risen to 21.32, indicating that debt service is becoming less comfortable relative to earnings.

Although the D/E ratio remains low at 0.83, the D/EBITDA multiple of 21.32 is elevated because EBITDA is depressed by high SG&A and non-cash charges. The company's debt level has stayed near $540M, but with flat revenue and volatile margins, the cushion for interest payments is thinning. Investors should monitor whether the recent EPS miss and lack of guidance signal further pressure on EBITDA, which would make the current leverage less sustainable.

Liquidity Buffer Thins Rapidly

The current ratio has fallen from 5.32 in 2024Q4 to 1.38 in 2026Q2, per balance sheet data, while cash dropped from $448M to $296M, indicating a shrinking liquidity cushion that may limit flexibility.

The quick ratio equals the current ratio, suggesting no inventory dependence, which is typical for a digital platform. However, the rapid decline in liquidity is concerning given the DSO spike and volatile cash flow. While the company still has positive working capital, the trend suggests that if collections continue to slow or if operating losses recur, the buffer could erode further. The asset-light model provides some resilience, but the shrinking cash position reduces the ability to weather a prolonged downturn or fund strategic initiatives.

Misapplied EV/EBITDA in a High-SBC Model

EV/EBITDA of 9.09 understates true valuation because EBITDA excludes stock-based compensation, which averaged $20M per quarter and often exceeded net income, per SEC filings, making the multiple appear artificially low.

For GDRX, SBC is a real economic cost that dilutes shareholders, yet it is excluded from EBITDA. Adjusting for SBC would reduce EBITDA significantly, potentially doubling the EV/EBITDA multiple. A more appropriate metric is EV/EBIT or EV/FCF, where FCF is adjusted for SBC, to capture the true cash-generative capacity. The forward EV/EBITDA of 4.95 is even more misleading, as it likely assumes a recovery in EBITDA that may not materialize given flat revenue growth and persistent marketing spend.

Download Financial Ratios Data

Includes 30+ ratios · 8 years · Updated daily

Consensus & Technical Research Suite
Open GDRX Terminal

GDRX Chart Terminal

WASM

Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.

Launch Terminal

Live Breakouts Feed

LIVE

High-probability breakout stocks crossing their pivot across 5 pattern engines.

Explore Setups

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

GDRX — Frequently Asked Questions

Quick answers to the most common questions about buying GDRX stock.

What is GoodRx Holdings, Inc.'s P/E ratio?

GoodRx Holdings, Inc.'s current P/E ratio is 38.9x. The historical average is 71.5x. This places it at the 50th percentile of its historical range.

What is GoodRx Holdings, Inc.'s EV/EBITDA?

GoodRx Holdings, Inc.'s current EV/EBITDA is 8.3x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 22.4x.

What is GoodRx Holdings, Inc.'s ROE?

GoodRx Holdings, Inc.'s return on equity (ROE) is 4.5%. The historical average is -7.2%.

Is GDRX stock overvalued?

Based on historical data, GoodRx Holdings, Inc. is trading at a P/E of 38.9x. This is at the 50th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.

What are GoodRx Holdings, Inc.'s profit margins?

GoodRx Holdings, Inc. has 92.8% gross margin and 11.0% operating margin. Operating margin between 10-20% is typical for established companies.

How much debt does GoodRx Holdings, Inc. have?

GoodRx Holdings, Inc.'s Debt/EBITDA ratio is 3.1x, indicating high leverage. A ratio between 2-4x is manageable but warrants monitoring.